Translate this page into:
Kala-azar in India: A Public Health Challenge in Transition
*Corresponding author: Zubaidabegum Kadar, Department of Community Medicine, Bhaarath Medical College and Hospital, Chennai, Tamil Nadu, India. zuaidabegum@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Kadar Z, Kalaivani A, Nachiyar GS. Kala-azar in India: A Public health challenge in transition. J Compr Health. 2026;14:9. doi: 10.25259/JCH_26_2025
Dear Editor,
Kala-azar, or visceral leishmaniasis (VL), is a life-threatening tropical disease caused by the Leishmania parasite and transmitted through bites of infected female sandflies. Common symptoms include prolonged fever, significant weight loss, enlarged spleen and liver, and anemia. Without timely treatment, the disease can be fatal. India contributes to about 18% of global kalaazar cases, with the highest burden found in Bihar, Jharkhand, Uttar Pradesh, and West Bengal. However, sporadic cases also emerge in other states such as Assam, Gujarat, Kerala, Madhya Pradesh, and Tamil Nadu, among others, indicating its wider geographical presence. The disease primarily affects poor, rural populations with limited access to healthcare. Despite ongoing elimination efforts, kala-azar remains a persistent public health challenge in India. Effective control requires improved surveillance, early diagnosis, accessible treatment, and community awareness to manage and ultimately eliminate the disease across both endemic and non-endemic regions of the country1-3
INDIA’S ACTION TOWARDS ELIMINATION OF KALA-AZAR
A critical review of the programmatic management of kala-azar is essential to assess the effectiveness of existing strategies, identify operational gaps in coordination, logistics, and surveillance, and recommend evidence-based improvements necessary for the sustained elimination of the disease across endemic and non-endemic regions [Figure 1].4,5

PROGRAM MANAGEMENT – LIMITATIONS OF PROGRAMMATIC MANAGEMENT
Effective program management is the backbone of the Kala-azar elimination campaign. While the strategy outlines collaborative roles between central and state governments, and external development partners, the World Health Organizations, non-governmental organizations, etc., gaps remain in coordination, logistics, and last-mile implementation.
VL-human immunodeficiency virus (HIV) co-infection is particularly concerning, as the dual burden undermines Kala-azar elimination. Patients co-infected with HIV are more likely to suffer recurrent or chronic infections due to weakened immunity. However, existing surveillance systems often inadequately cover this aspect. Therefore, integrating HIV programs with VL surveillance, including cross-training of field workers and introducing joint monitoring frameworks, is vital for early detection and timely intervention. Box 1 highlights the key government initiatives taken by Government of India.
Despite the presence of clearly defined operational activities (drug procurement, diagnostics, cold chain maintenance, etc.), actual ground-level execution often suffers from poor inter-departmental coordination, inconsistent supply chains, and delays in drug dispatch and usage reporting. Feedback mechanisms between field-level workers and district officials are weak or obsolete in several endemic districts.
A key limitation is the absence of a centralized monitoring dashboard that integrates real-time data on cases, indoor residual sparying (IRS) progress, drug supply status, and relapse monitoring. Such a platform could facilitate evidence-based corrections in the program’s implementation strategies.
|
SEAR: South-East Asia Region, PHC: Primary health centre
In summary, while the government’s efforts toward Kalaazar elimination are commendable, sustained progress will depend on agile program management, robust monitoring systems, inclusion of private health data, and innovative community engagement practices [Figure 1].
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
Patient’s consent not required as there are no patients in this study.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Global Leishmaniasis Surveillance, 2020-2021 Vol 97. Geneva: World Health Organization; 2022. p. :575-590.
- [Google Scholar]
- World Health Assembly (WHA 60.13) on the Control of Leishmaniasis Geneva, Switzerland: World Health Assembly; 2007. p. :5.
- [Google Scholar]
- Visceral Leishmaniasis: A Global Overview. J Glob Health Sci. 2020;2:e3.
- [CrossRef] [Google Scholar]
- Regional office for South-East Asia In: Independent Assessment of Kala-Azar Elimination Programme in India. New Delhi: WHO SEARO; 2020. p. :1-106.
- [Google Scholar]
- National Kala-Azar Elimination Programme: National Center for Vector Borne Diseases Control (NCVBDC) Available from: https://ncvbdc.mohfw.gov.in/index4 [Last accessed on 2023 Nov 02]
- [Google Scholar]